FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/06/053378 [Registered on: 01/06/2023] Trial Registered Prospectively
Last Modified On: 31/05/2023
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Single Arm Study 
Public Title of Study   To evaluate the efficacy of leuc capsule in leucorrhoea 
Scientific Title of Study   SINGLE ARMED CLINICAL STUDY TO EVALUATED EFFICACY OF LEUC CAPSULE IN LEUCORRHOEA  
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
JSAM/IECHR/147/04-2022  Protocol Number 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Vaishali Dave 
Designation  Associate professor  
Affiliation  JS Ayurveda Mahavidyalaya 
Address  Department of Prasutitatra JS Ayurved Mahavidyalay
College road , yogiraj society
Kheda
GUJARAT
387001
India 
Phone  09662140078  
Fax    
Email  vaishalivasavda@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Vaishali Dave 
Designation  Associate professor  
Affiliation  JS Ayurveda Mahavidyalaya 
Address  Department of Prasutitantra evam striroga JS Ayurved Mahavidyalay
College road , yogiraj society
Kheda
GUJARAT
387001
India 
Phone  09662140078  
Fax    
Email  vaishalivasavda@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Vaishali Dave 
Designation  Assistant professor  
Affiliation  JS Ayurveda Mahavidyalaya 
Address  Prasuti tantra and Striroga department JS Ayurved Mahavidyalay
College road , yogiraj society
Kheda
GUJARAT
387001
India 
Phone  09662140078  
Fax    
Email  vaishalivasavda@gmail.com  
 
Source of Monetary or Material Support  
“PUNARVASU” Near, Santram Deri Gate, Petlad Road, Nadiad – 387002 
 
Primary Sponsor  
Name  PUNARVASU PHARMACY 
Address  “PUNARVASU” Near, Santram Deri Gate, Petlad Road, Nadiad – 387002 
Type of Sponsor  Pharmaceutical industry-Indian 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DrVaishali Dave  JS Ayurveda Mahavidyalaya   OPD no 132, PD patel Ayurveda hospital and JS Ayurved Mahavidyalay College road , yogiraj society
Kheda
GUJARAT 
09662140078
9662140078
vaishalivasavda@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL ETHICS COMMITTEE   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:N899||Noninflammatory disorder of vagina, unspecified. Ayurveda Condition: YONIROGAH/YONI-VYAPADAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugOther than Classical(1) Medicine Name: LEUC CAPSULE, Reference: NA, Route: Oral, Dosage Form: Capsules, Dose: 3(NA), Frequency: tds, Bhaishajya Kal: Pragbhakta, Duration: 14 Days, anupAna/sahapAna: Yes(details: Koshna Jala), Additional Information: --
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  55.00 Year(s)
Gender  Female 
Details  Patients having any complaint of discharge per vagina, Itching sensation at vulva, Burning sensation in vagina, Pain in vagina, Foul smell from vagina , backache and pelvic pain. 
 
ExclusionCriteria 
Details  Female patients having pregnancy, breast feeding or post-delivery period.
Patients with any reproductive tract malignancy.
Patients with other systemic illness.
Patients with positive history of venereal diseases
Patients who are using CU-T or chemical method of contraception.
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
white discharge from vagina will reduce  at 4 week 
 
Secondary Outcome  
Outcome  TimePoints 
no reoccurrence of white discharge   6 weeks 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Post Marketing Surveillance 
Date of First Enrollment (India)   14/06/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="1"
Days="1" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   NA  
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices).

  2. What additional supporting information will be shared?
    Response -  Study Protocol
    Response -  Statistical Analysis Plan
    Response - Informed Consent Form
    Response - Clinical Study Report
    Response -  Analytic Code

  3. Who will be able to view these files?
    Response - Anyone

  4. For what types of analyses will this data be available?
    Response - To achieve aims in the approved proposal.

  5. By what mechanism will data be made available?
    Response - Proposals should be directed to [vaishalivasavda@gmail.com].

  6. For how long will this data be available start date provided 01-01-2023 and end date provided 12-01-2025?
    Response - Beginning 3 months and ending 5 years following article publication.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - NIL
Brief Summary  

Leucorrhoea or white discharge is a complaint with which each woman suffers at least once in a lifetime. It refers to the white or yellowish discharge from the vaginal canal. The symptoms of swetapradara either physiological or pathological results into great discomfort and deep agony in the individuals1 Leucorrhoea is found significantly more in married females as compared to unmarried, pregnant as compared to non-pregnant, and women of lower socioeconomic status with high parity.2Symptoms of Leucorrhoea are somewhat similar to Shwetapradara mentioned in Ayurvedic literature but there is no separate chapter given in Brihatrayee. Commentator Chakrapani has explained the word Pandura-Asrigdara as Shwetapradara in his commentary.3Taking into account the side effects and adverse effects of contemporary management , The Ayurvedic management can be recommended as a safer, feasible and effective therapy for the management of leucorrhea. In this study, Ayurveda management by LEUC CAPSULE (combination of Extract of Ashwagandha, Lodhra, Udumber, Guduchi, Vruddhadaru ; Kukutanda twak bhasma, Godanti bhasma, sharkara ) will be carried out to evaluate the efficacy in leucorrhoea.

 
Close